CNKSR3 Activators
CNKSR3 Activators are a diverse set of compounds that impinge upon various intracellular signaling cascades to augment the activity of CNKSR3. Forskolin and Isoproterenol function by raising intracellular cAMP levels, thus potentially activating protein kinase A (PKA), which could subsequently phosphorylate and enhance CNKSR3 function in signal transduction. Similarly, the non-specific phosphodiesterase inhibitor IBMX increases cAMP by preventing its degradation, possibly leading to enhanced CNKSR3 signaling. Phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC), could also augment CNKSR3's activity by modifying protein-protein interactions or its phosphorylation state. The PI3K inhibitor LY294002 and the MEK inhibitor U0126 might indirectly affect CNKSR3 by altering the equilibrium of cellular signaling pathways, potentially leading to an enhanced role for CNKSR3 in these altered signaling contexts.
Moreover, certain compounds exert their effects by modulating intracellular levels of second messengers or by influencing the activities of other kinases that could indirectly enhance CNKSR3 functions. Anisomycin activates JNK signaling, which could indirectly affect CNKSR3's role within this pathway. The calcium ionophores A23187 and Ionomycin raise intracellular calcium levels, likely impacting CNKSR3 through calcium-dependent signaling processes. Sphingosine-1-phosphate, throughits receptor-mediated actions, might enhance CNKSR3 activity by modifying the internal signaling milieu in favor of CNKSR3-involved pathways. Epigallocatechin gallate (EGCG), with its kinase inhibitory properties, might reduce inhibitory phosphorylations or protein interactions that normally suppress CNKSR3 function, thereby enhancing its signaling capacity. Lastly, Zaprinast, by inhibiting cGMP-specific phosphodiesterase, could increase cGMP levels, which may influence CNKSR3's activity by modulating signaling processes that converge upon or are modulated by CNKSR3. Collectively, these chemical activators, through their targeted biochemical actions, serve to potentiate the activity of CNKSR3 by influencing the balance and intensity of intracellular signaling pathways in which CNKSR3 is a critical component.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). CNKSR3, being a scaffold protein, interacts with components of the PKC signaling pathway. Activation of PKC can lead to the phosphorylation of downstream effectors that interact with CNKSR3, thereby enhancing its ability to mediate signal transduction processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing the production of cyclic AMP (cAMP). Elevated cAMP levels can activate PKA, which in turn can phosphorylate proteins that associate with CNKSR3, resulting in the enhancement of CNKSR3-mediated signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. CNKSR3's activity can be modulated by calcium-dependent signaling pathways, and the elevation of calcium levels can enhance the interactions of CNKSR3 with calcium-binding partners, thereby influencing its scaffold functions. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
This cAMP analog is resistant to degradation and activates cAMP-dependent pathways. By maintaining elevated cAMP levels, 8-Bromo-cAMP enhances PKA activity and subsequent phosphorylation of associated proteins, potentially increasing CNKSR3's scaffolding efficiency in signal transduction. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases. By modulating kinase activity, EGCG may alter the phosphorylation state of proteins interacting with CNKSR3, which could enhance CNKSR3's efficiency in coordinating signaling events. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which are coupled to G-proteins. Activation of these pathways can lead to the modulation of proteins that interact with CNKSR3, thereby enhancing its activity as a signaling scaffold. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a selective PKC inhibitor, but it can paradoxically activate PKC in a chronic setting. Chronic exposure to Bisindolylmaleimide I may lead to compensatory upregulation of PKC activity, potentially increasing the interaction with CNKSR3 and enhancing its signaling capacity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cAMP analog that activates cAMP-dependent pathways. Like 8-Bromo-cAMP, it can sustain PKA activity, which can phosphorylate substrates interacting with CNKSR3, potentially optimizing CNKSR3's scaffolding functions. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to Ionomycin. It increases intracellular calcium levels, thereby potentially enhancing CNKSR3's interaction with calcium-dependent proteins and modulating its scaffolding ability. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases leads to increased phosphorylation levels of proteins, possibly affecting proteins that associate with CNKSR3 and thus enhancing CNKSR3's role in signaling pathways. | ||||||